Risk of HPV-linked second cancers up after anal cancer

June 15, 2017

(HealthDay)—Survivors of squamous cell carcinoma of the anus (SCCA) have an elevated risk of human papillomavirus (HPV)-related second primary malignancies (SPMs), according to a study published online June 13 in Cancer.

Rebecca A. Nelson, Ph.D., and Lily L. Lai, M.D., from City of Hope in Duarte, Calif., used population-based data from 1992 through 2012 to identify patients with SCCA and examined their risk of HPV-related SPMs. To determine excess risk, they calculated standardized incidence ratios (SIRs) defined as observed to expected cases.

The researchers found that 416 of the 10,537 patients with SCCA developed HPV-related SPMs, which corresponded to an overall SIR of 21.5. Compared with women, men had higher SIR (35.8 versus 12.8). For a second SCCA, men had markedly higher SIRs than women (127.5 versus 47.0); for oral cavity and pharyngeal cancers, the SIRs were elevated in men and women (3.1 and 4.4, respectively). For sex-specific sites the SIRs were also elevated, with an SIR of 19.6 for male genital cancers and 8.3 for female genital cancers.

"Patients with index SCCA are at an increased risk of subsequent HPV-related SPMs," the authors write. "The elevated risk is most striking in patients with second primary SCCAs; however, the risk of second cancers also appears to be increased in other HPV-related sites."

Explore further: Increased cancer risk for childhood kidney recipients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Increased cancer risk for childhood kidney recipients

April 5, 2017
(HealthDay)—Childhood kidney recipients have increased cancer risk, according to a study published online March 29 in the American Journal of Transplantation.

Study tracks patterns of US cases of anal canal carcinoma

April 2, 2013
(HealthDay)—Available screening and identification of human papillomavirus likely contributed to the increased incidences of squamous cell carcinoma of the anal canal (SCCA) and anal carcinoma in situ (CIS) after 1997, ...

Index CRC tumor site impacts increased CA risk for survivors

July 15, 2013
(HealthDay)—The location of index colorectal cancer (CRC) affects the incidence of second cancer after CRC, according to a study published online July 15 in Cancer.

Researchers uncover new potential biomarker and therapeutic target for aggressive breast cancer

April 29, 2011
(PhysOrg.com) -- In an analysis of more than 1,300 human breast tissue samples, a team of Stony Brook University School of Medicine researchers discovered a possible role of the squamous cell carcinoma antigen (SCCA) in the ...

Ovarian cancer rates declining in breast cancer survivors

January 8, 2013
(HealthDay)—Primary ovarian cancer incidence is declining in the United States, both among the general population and among breast cancer survivors, according to research published online Jan. 2 in the Journal of Clinical ...

Infection risk up before chronic immune thrombocytopenia

February 4, 2016
(HealthDay)—The incidence of primary chronic immune thrombocytopenia (cITP) is 2.30/100,000 person-years, and incidence is associated with increased risk of infections within the five years before cITP diagnosis, according ...

Recommended for you

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Fundamental research enhances understanding of major cancer gene

October 19, 2017
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge and the AstraZeneca IMED Biotech Unit reveals ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.